Inovio Pharmaceuticals Share Price Today
(NASDAQ: INO)

Name: Inovio Pharmaceuticals Share Price Today (NASDAQ: INO) - Inovio Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Inovio Pharmaceuticals share price is $1.94 & ₹164.29 as on 1 May 2025, 2.30 'hrs' IST

$1.94

▲

0.03

(1.57%)

Market is closed - opens 7 PM, 01 May 2025

View live Inovio Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Inovio Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inovio Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Inovio Pharmaceuticals share price movements

Today's Low: $1.84
Today's High: $1.95
$1.94
5.15%
Downside
Day's Volatility :5.64%
Upside
0.51%
52 Weeks Low: $1.42
52 Weeks High: $13.44
$1.94
26.8%
Downside
52 Weeks Volatility :89.43%
Upside
85.57%

Inovio Pharmaceuticals (INO) Returns

Period	Inovio Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.09%	-5.5%	0.0%
6 Months	-64.02%	-6.0%	0.0%
1 Year	-83.61%	-0.8%	0.0%
3 Years	-94.69%	6.9%	-5.1%

Inovio Pharmaceuticals (INO) Key Statistics

in dollars & INR

Previous Close	$1.91
Open	$1.87
Today's High	$1.95
Today's Low	$1.84
Market Capitalization	$71.2M
Today's Volume	$219.1K
52 Week High	$13.44
52 Week Low	$1.42
Revenue TTM	$217.8K
EBITDA	$-110.6M
Earnings Per Share (EPS)	$-3.95
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-115.42%

How to invest in Inovio Pharmaceuticals Stock (INO) from India?

It is very easy for Indian residents to invest directly in Inovio Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inovio Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inovio Pharmaceuticals or INO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inovio Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inovio Pharmaceuticals shares which would translate to 0.437 fractional shares of Inovio Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inovio Pharmaceuticals, in just a few clicks!

Returns in Inovio Pharmaceuticals (INO) for Indian investors in Rupees

The Inovio Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Inovio Pharmaceuticals investment value today

Current value as on today

₹18,206

Returns

₹81,794

(-81.79%)

Returns from Inovio Pharmaceuticals Stock

₹83,261 (-83.26%)

Dollar Returns

₹1,467 (+1.47%)

Indian investors sentiment towards Inovio Pharmaceuticals (INO)

-33%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Inovio Pharmaceuticals Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inovio Pharmaceuticals

Deep Track Capital, LP
8.51%
BlackRock Inc
5.20%
Vanguard Group Inc
4.56%
Stonepine Capital Management Llc
2.86%
AIGH Capital Management, LLC
1.78%
Bank of America Corp
1.75%

Analyst Recommendation on Inovio Pharmaceuticals

Rating

Trend

Buy

55%Buy

44%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Inovio Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Inovio Pharmaceuticals Stock (INO)

What analysts predicted

Upside of 303.78%

Target:

$7.83

Current:

$1.94

Insights on Inovio Pharmaceuticals Stock (Ticker Symbol: INO)

Price Movement
In the last 6 months, INO stock has moved down by -65.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 100.76K → 116.99K (in $), with an average increase of 13.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -25.16B → -19.38M (in $), with an average increase of 129741.6% per quarter
INO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 78.7% return, outperforming this stock by 162.1%
INO vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 92.8% return, outperforming this stock by 187.0%
Price to Sales
ForINO every $1 of sales, investors are willing to pay $242.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Inovio Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Inovio Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Inovio Pharmaceuticals (INO) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inovio Pharmaceuticals, Inc.	16.56%	-64.02%	-83.61%	-94.69%	-98.59%
Biontech Se	14.33%	-7.95%	15.74%	-28.71%	127.41%
Regeneron Pharmaceuticals, Inc.	-7.79%	-32.13%	-37.03%	-12.75%	5.0%
Vertex Pharmaceuticals Incorporated	3.75%	5.66%	25.06%	91.98%	90.0%
Alnylam Pharmaceuticals, Inc.	0.61%	-3.48%	71.59%	85.05%	88.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inovio Pharmaceuticals, Inc.	NA	NA	0.0	-2.61	-1.15	-0.49	NA	1.9
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inovio Pharmaceuticals, Inc.	Buy	$71.2M	-98.59%	NA	0.0%
Biontech Se	Buy	$29.5B	127.41%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.0%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$127.6B	90.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	88.33%	NA	-12.37%

About Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Organization	Inovio Pharmaceuticals
Employees	134
CEO	Dr. Jacqueline E. Shea Ph.D.
Industry	Health Technology

Management People of Inovio Pharmaceuticals

Name	Title
Dr. Jacqueline E. Shea Ph.D.	CEO, President & Director
Mr. Peter D. Kies	Chief Financial Officer
Dr. Michael Sumner M.D.	Chief Medical Officer
Dr. Laurent M. Humeau Ph.D.	Chief Scientific Officer & Chairman of the Scientific Advisory Board
Thomas Hong	Manager of Investor Relations
Mr. Robert L. Crotty J.D.	General Counsel & Chief Compliance Officer
Mr. E. J. Brandreth MBA	Senior Vice President of Quality Assurance
Dr. Jeffrey Skolnik	Senior Vice President of Clinical Development
Mr. Robert J. Juba Jr.	Senior Vice President of Biological Manufacturing & Clinical Supply Management
Mr. Shawn D. Bridy M.A., M.B.A.	Senior Vice President of Business Development

Important FAQs about investing in INO Stock from India :

What is Inovio Pharmaceuticals share price today?

Inovio Pharmaceuticals share price today stands at $1.94, Open: $1.87 ; Previous Close: $1.91 ; High: $1.95 ; Low: $1.84 ; 52 Week High: $13.44 ; 52 Week Low: $1.42.

The stock opens at $1.87, after a previous close of $1.91. The stock reached a daily high of $1.95 and a low of $1.84, with a 52-week high of $13.44 and a 52-week low of $1.42.

Can Indians buy Inovio Pharmaceuticals shares?

Yes, Indians can invest in the Inovio Pharmaceuticals (INO) from India.

With INDmoney, you can buy Inovio Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inovio Pharmaceuticals at zero transaction cost.

How can I buy Inovio Pharmaceuticals shares from India?

It is very easy to buy Inovio Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inovio Pharmaceuticals (INO) be purchased?

Yes, you can buy fractional shares of Inovio Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Inovio Pharmaceuticals stocks?

To start investing in Inovio Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.